Literature DB >> 10971517

Enhancement of natural killer (NK) cell cytotoxicity and induction of NK cell-derived interferon-gamma (IFN-gamma) display different kinetics during experimental infection with Trypanosoma cruzi.

C Une1, J Andersson, M L Eloranta, D Sunnemark, R A Harris, A Orn.   

Abstract

Early immunological activation involves an initial phase of cytokine activity and involvement of cell types such as NK cells. Such early immune responses are often decisive in resolution of microbial infection. NK cells reduce parasitaemia and enhance survival in experimental Trypanosoma cruzi infection, although the nature of these protective effects is not well understood. In this study, a detailed analysis of innate cytokine induction in the absence and presence of NK cells during the first 8 days of infection was performed. Following intraperitoneal infection with a high dose of parasites, reverse transcriptase-polymerase chain reaction showed that splenic mRNA for IFN-gamma appeared as a peak 24 h after infection and then reappeared 2-3 days later. In NK-depleted animals the first peak of IFN-gamma was absent and the second wave was slightly delayed. mRNA for IL-12 and tumour necrosis factor-alpha (TNF-alpha) as well as IFN-alpha protein in serum was only recorded 24 h after infection, at the same time as the IFN-gamma peak. NK depletion resulted in a small decrease of IL-12 mRNA levels, whereas TNF-alpha and IFN-alpha were not affected. NK cytotoxicity remained elevated throughout the 8 days and thus did not parallel the expression of IFN-gamma production by NK cells. We conclude that NK cell cytokine production and cytolytic activity play different roles in response to challenge with T. cruzi.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10971517      PMCID: PMC1905720          DOI: 10.1046/j.1365-2249.2000.01318.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  36 in total

1.  Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice.

Authors:  E Castaños-Velez; S Maerlan; L M Osorio; F Aberg; P Biberfeld; A Orn; M E Rottenberg
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

2.  Enhanced NK cell activity in mice injected with interferon and interferon inducers.

Authors:  M Gidlund; A Orn; H Wigzell; A Senik; I Gresser
Journal:  Nature       Date:  1978-06-29       Impact factor: 49.962

3.  Increased serum levels of an interferon-like activity during the acute period of experimental infection with different strains of Trypanosoma cruzi.

Authors:  G Sonnenfeld; F Kierszenbaum
Journal:  Am J Trop Med Hyg       Date:  1981-11       Impact factor: 2.345

4.  In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections.

Authors:  S G Reed
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

5.  Increased natural killer cell activity in experimental American trypanosomiasis.

Authors:  F M Hatcher; R E Kuhn; M C Cerrone; R C Burton
Journal:  J Immunol       Date:  1981-09       Impact factor: 5.422

6.  Enhanced resistance to acute infection with Trypanosoma cruzi in mice treated with an interferon inducer.

Authors:  S L James; T L Kipnis; A Sher; R Hoff
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

7.  Lysis of murine macrophages infected with intracellular pathogens by interleukin 2-activated killer (LAK) cells in vitro.

Authors:  M Resnick; N Roguel; H Bercovier; C Enk; S Frankenburg; E Kedar
Journal:  Cell Immunol       Date:  1988-04-15       Impact factor: 4.868

8.  Interleukin 2 induces gamma-interferon production: participation of macrophages and NK-like cells.

Authors:  I Kawase; C G Brooks; K Kuribayashi; S Olabuenaga; W Newman; S Gillis; C S Henney
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

9.  Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice.

Authors:  J F Bukowski; B A Woda; R M Welsh
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

10.  Recycling and target binding capacity of human natural killer cells.

Authors:  M Ullberg; M Jondal
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

View more
  7 in total

1.  During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.

Authors:  Malcolm S Duthie; Monika Wleklinski-Lee; Sherilyn Smith; Toshinori Nakayama; Masaru Taniguchi; Stuart J Kahn
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigs.

Authors:  Gourapura J Renukaradhya; Konstantin Alekseev; Kwonil Jung; Ying Fang; Linda J Saif
Journal:  Viral Immunol       Date:  2010-10       Impact factor: 2.257

3.  NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms.

Authors:  Thorsten Lieke; Sebastian E B Graefe; Ulricke Klauenberg; Bernhard Fleischer; Thomas Jacobs
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

4.  Contribution of NK, NK T, gamma delta T, and alpha beta T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi.

Authors:  Luiz Roberto Sardinha; Rosa Maria Elias; Tainá Mosca; Karina R B Bastos; Cláudio R F Marinho; Maria Regina D'Império Lima; José M Alvarez
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

5.  Role of IFN-alpha/beta and IL-12 in the activation of natural killer cells and interferon-gamma production during experimental infection with Trypanosoma cruzi.

Authors:  C Une; J Andersson; A Orn
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

6.  The Ly49E Receptor Inhibits the Immune Control of Acute Trypanosoma cruzi Infection.

Authors:  Jessica Filtjens; Nicolas Coltel; Sabrina Cencig; Sylvie Taveirne; Els Van Ammel; Aline Van Acker; Tessa Kerre; Patrick Matthys; Tom Taghon; Bart Vandekerckhove; Yves Carlier; Carine Truyens; Georges Leclercq
Journal:  Front Immunol       Date:  2016-11-10       Impact factor: 7.561

Review 7.  CD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?

Authors:  Fernando Dos Santos Virgilio; Camila Pontes; Mariana Ribeiro Dominguez; Jonatan Ersching; Mauricio Martins Rodrigues; José Ronnie Vasconcelos
Journal:  Mediators Inflamm       Date:  2014-07-01       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.